Publication | Open Access
Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma
51
Citations
50
References
2021
Year
NCT01876212.
| Year | Citations | |
|---|---|---|
Page 1
Page 1